FDA clears St. Jude trial of electrical-stimulation device for depression

02/8/2008 | Star Tribune (Minneapolis-St. Paul, Minn.)

St. Jude Medical has received an investigational-device exemption from the FDA to conduct a clinical trial for its libra deep-brain stimulation system designed to treat severe depression. Neuronetics and Northstar Neuroscience are also exploring electrical stimulation as a treatment for depression.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
PRINCIPAL ENGINEER - R&D - 14000009CP
Abbott
Chicago, IL
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX